Analystreport

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) had its "buy" rating re-affirmed by analysts at Cantor Fitzgerald.

VALEANT PHARMACEUTICALS  (VRX) 
Last valeant pharmaceuticals earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.valeant.com